Healthequity (Germany) Market Value
| 2HE Stock | EUR 99.00 2.00 2.06% |
| Symbol | Healthequity |
Healthequity 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Healthequity's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Healthequity.
| 12/05/2022 |
| 11/24/2024 |
If you would invest 0.00 in Healthequity on December 5, 2022 and sell it all today you would earn a total of 0.00 from holding Healthequity or generate 0.0% return on investment in Healthequity over 720 days. Healthequity is related to or competes with Evolent Health, Superior Plus, NMI Holdings, Origin Agritech, SIVERS SEMICONDUCTORS, Talanx AG, and NorAm Drilling. HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and ... More
Healthequity Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Healthequity's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Healthequity upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.97 | |||
| Information Ratio | 0.193 | |||
| Maximum Drawdown | 18.02 | |||
| Value At Risk | (2.19) | |||
| Potential Upside | 4.96 |
Healthequity Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Healthequity's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Healthequity's standard deviation. In reality, there are many statistical measures that can use Healthequity historical prices to predict the future Healthequity's volatility.| Risk Adjusted Performance | 0.1952 | |||
| Jensen Alpha | 0.4631 | |||
| Total Risk Alpha | 0.2093 | |||
| Sortino Ratio | 0.2435 | |||
| Treynor Ratio | 0.5249 |
Healthequity Backtested Returns
Healthequity appears to be very steady, given 3 months investment horizon. Healthequity holds Efficiency (Sharpe) Ratio of 0.24, which attests that the entity had a 0.24% return per unit of standard deviation over the last 3 months. By evaluating Healthequity's technical indicators, you can evaluate if the expected return of 0.59% is justified by implied risk. Please utilize Healthequity's market risk adjusted performance of 0.5349, and Risk Adjusted Performance of 0.1952 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Healthequity holds a performance score of 18. The company retains a Market Volatility (i.e., Beta) of 1.15, which attests to a somewhat significant risk relative to the market. Healthequity returns are very sensitive to returns on the market. As the market goes up or down, Healthequity is expected to follow. Please check Healthequity's market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to make a quick decision on whether Healthequity's current trending patterns will revert.
Auto-correlation | 0.15 |
Insignificant predictability
Healthequity has insignificant predictability. Overlapping area represents the amount of predictability between Healthequity time series from 5th of December 2022 to 30th of November 2023 and 30th of November 2023 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Healthequity price movement. The serial correlation of 0.15 indicates that less than 15.0% of current Healthequity price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.15 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 53.33 |
Healthequity lagged returns against current returns
Autocorrelation, which is Healthequity stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Healthequity's stock expected returns. We can calculate the autocorrelation of Healthequity returns to help us make a trade decision. For example, suppose you find that Healthequity has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Healthequity regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Healthequity stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Healthequity stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Healthequity stock over time.
Current vs Lagged Prices |
| Timeline |
Healthequity Lagged Returns
When evaluating Healthequity's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Healthequity stock have on its future price. Healthequity autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Healthequity autocorrelation shows the relationship between Healthequity stock current value and its past values and can show if there is a momentum factor associated with investing in Healthequity.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Healthequity Stock
When determining whether Healthequity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Healthequity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock:Check out Healthequity Correlation, Healthequity Volatility and Healthequity Alpha and Beta module to complement your research on Healthequity. For more detail on how to invest in Healthequity Stock please use our How to Invest in Healthequity guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Healthequity technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.